Skip to main content
Download PDF
- Main
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- Shah, Manish A;
- Wainberg, Zev A;
- Catenacci, Daniel VT;
- Hochster, Howard S;
- Ford, James;
- Kunz, Pamela;
- Lee, Fa-Chyi;
- Kallender, Howard;
- Cecchi, Fabiola;
- Rabe, Daniel C;
- Keer, Harold;
- Martin, Anne-Marie;
- Liu, Yuan;
- Gagnon, Robert;
- Bonate, Peter;
- Liu, Li;
- Gilmer, Tona;
- Bottaro, Donald P
Published Web Location
https://doi.org/10.1371/journal.pone.0276211Abstract
[This corrects the article DOI: 10.1371/journal.pone.0054014.].
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.